Commonwealth Equity Services
SGMO

Commonwealth Equity Services’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Commonwealth Equity Services’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-157,811
Closed -$39K – 4553
2026
Q1 		$39K Hold
157,811
– – ﹤0.01% 4219
2025
Q4 		$66.3K Buy
157,811
+21,487
+16% +$11.4K ﹤0.01% 4158
2025
Q3 		$92K Sell
136,324
-11,990
-8% -$6.46K ﹤0.01% 4098
2025
Q2 		$80K Buy
148,314
+50,000
+51% +$29.7K ﹤0.01% 4099
2025
Q1 		$64K Buy
98,314
+2,813
+3% +$2.98K ﹤0.01% 4043
2024
Q4 		$97K Buy
95,501
+27,353
+40% +$50K ﹤0.01% 3911
2024
Q3 		$59K Buy
68,148
+8,400
+14% +$6.15K ﹤0.01% 3916
2024
Q2 		$21K Sell
59,748
-204
-0.3% -$110 ﹤0.01% 3968
2024
Q1 		$40K Buy
59,952
+28,304
+89% +$20.5K ﹤0.01% 3916
2023
Q4 		$17K Sell
31,648
-18,648
-37% -$8.6K ﹤0.01% 3829
2023
Q3 		$30K Buy
50,296
+4,436
+10% +$4.75K ﹤0.01% 3705
2023
Q2 		$60K Buy
45,860
+18,895
+70% +$25.8K ﹤0.01% 3641
2023
Q1 		$47 Buy
26,965
+387
+1% +$1.1K ﹤0.01% 3588
2022
Q4 		$83K Buy
26,578
+2,754
+12% +$10.7K ﹤0.01% 3445
2022
Q3 		$116K Hold
23,824
– – ﹤0.01% 3339
2022
Q2 		$98K Buy
23,824
+818
+4% +$3.54K ﹤0.01% 3379
2022
Q1 		$133K Sell
23,006
-8,814
-28% -$52.4K ﹤0.01% 3430
2021
Q4 		$238K Sell
31,820
-1,218
-4% -$10.6K ﹤0.01% 3157
2021
Q3 		$297K Sell
33,038
-2,391
-7% -$23.6K ﹤0.01% 2950
2021
Q2 		$424K Sell
35,429
-1,100
-3% -$12.5K ﹤0.01% 2597
2021
Q1 		$457K Buy
36,529
+15,514
+74% +$209K ﹤0.01% 2403
2020
Q4 		$327K Sell
21,015
-1,312
-6% -$15.4K ﹤0.01% 2498
2020
Q3 		$210K Sell
22,327
-1,000
-4% -$10.8K ﹤0.01% 2679
2020
Q2 		$209K Buy
23,327
+6,687
+40% +$62K ﹤0.01% 2558
2020
Q1 		$106K Sell
16,640
-9,672
-37% -$71.8K ﹤0.01% 2567
2019
Q4 		$220K Buy
26,312
+11,119
+73% +$102K ﹤0.01% 2545
2019
Q3 		$137K Buy
15,193
+678
+5% +$7.61K ﹤0.01% 2630
2019
Q2 		$156K Sell
14,515
-1,081
-7% -$11.5K ﹤0.01% 2574
2019
Q1 		$148K Sell
15,596
-11,824
-43% -$121K ﹤0.01% 2534
2018
Q4 		$314K Sell
27,420
-398
-1% -$4.94K ﹤0.01% 1979
2018
Q3 		$471K Buy
27,818
+10,185
+58% +$155K ﹤0.01% 1821
2018
Q2 		$250K Buy
17,633
+2,447
+16% +$40.6K ﹤0.01% 2285
2018
Q1 		$288K Buy
+15,186
New +$325K ﹤0.01% 2090
2017
Q4 		– Sell
-11,193
Closed -$168K – 2714
2017
Q3 		$168K Hold
11,193
– – ﹤0.01% 2337
2017
Q2 		$99K Buy
+11,193
New +$71.8K ﹤0.01% 2375

Other funds holding SGMO

AIM
Axiom Investment Management New York $150M AUM
HIG
Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Commonwealth Equity Services's SGMO Position: Q2 2026 in Review

Commonwealth Equity Services sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 157,811 shares — an estimated $39K sold.

Commonwealth Equity Services first reported a position in SGMO in Q2 2017 and held it in 35 quarters. The position peaked at $471K in Q3 2018. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

  • Commonwealth Equity Services reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
  • Commonwealth Equity Services sold 157,811 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $39K.
  • Commonwealth Equity Services first reported a position in SANGAMO THERAPEUTICS INC in Q2 2017 and held it in 35 quarters.
  • Commonwealth Equity Services's SANGAMO THERAPEUTICS INC position peaked at $471K in Q3 2018.
  • 2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.